Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Liver Cancer treatment details. Biologic therapy. Kantonsspital St. Gallen, St. Gallen, Switzerland



Survival: 9.3 months
   
Toxicity Grade: 4
   
Treatments: Biologic therapy
   
Drugs:
Country: Switzerland
   
City/State/Province: St. Gallen
   
Hospital: Kantonsspital St. Gallen
   
Journal: Link
   
Date: 3/2010

Description:
Patients:
This phase II study involved 45 hepatocellular carcinoma patients who had not received prior systemic treatment. The median age was 63 years and 87% were male.

Treatment:
Patients were treated with the biologic therapy agent sunitinib, which is a tyrosine kinase inhibitor that interferes with cancer cell growth.

Toxicities:
The highest reported toxicity level was grade 4 and included fatigue and anemia. The most common adverse events were anemia (grade 1-4), thrombocytopenia (grades 1-3), and fatigue (grade 1-4).

Results:
The median overall survival was 9.3 months.

Support:
This study was supported by Pfizer, Inc., makers of sunitinib (trade name: SUTENT).

Correspondence: Dr. Dieter Koeberle; email: dieter.koeberle@kssg.ch

E-mail to a Friend Email Physician More Information